Evidence map›Paper›PMID 41590731›Full record

ArticleMarine drugs2026

Chemical Investigation of the Global Regulator

Qing Gong, Wei Wang, Yujie Zhao, Xiaoying Wang, Xuelian Bai, Huawei Zhang

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing GongSchool of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
Wei WangSchool of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
Yujie ZhaoSchool of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
Xiaoying WangSchool of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
Xuelian BaiCollege of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Huawei ZhangSchool of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.ORCID 0000-0002-2430-3845

Funding

the National Key Research and Development Program of China 2022YFC2804203
6 · The paper itself

Abstract

A growing body of evidence indicates that artificial manipulation of transcriptional regulation is a powerful approach to activate cryptic biosynthetic gene clusters (BGCs) of secondary metabolites (SMs) in fungi. In this study, one mutant strain MNP-2-OE::

Indexed as

Antifungal AgentsAspergillusFungal ProteinsTranscription FactorsAnthraquinonesArctic RegionsCandida albicansGene Expression Regulation, FungalHCT116 CellsHumansMicrobial Sensitivity TestsMultigene FamilyMutationPeptide SynthasesPolyketide SynthasesSecondary MetabolismAnthraquinonesAntifungal AgentsFungal Proteinsnon-ribosomal peptide synthasePeptide SynthasesPolyketide SynthasesTranscription FactorsactivationAspergillusbiosynthetic gene clusterglobal transcription regulatorsecondary metabolites

Identifiers

PMID41590731
PMCPMC12843210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.